Leaked data on Gilead’s remdesivir suggest drug didn’t help patients with COVID-19 | BioPharma Dive

Patients in China who received Gilead’s experimental antiviral drug remdesivir did not appear to recover from COVID-19 any faster than those given a placebo, according to a summary of data posted in error Thursday on the World Health Organization’s website.

Leaked data on Gilead’s remdesivir suggest drug didn’t help patients with COVID-19 | BioPharma Dive